List of Excipients in API deferasirox
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing deferasirox
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | LACTOSE MONOHYDRATE | |
| Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | MAGNESIUM STEARATE | |
| Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | POVIDONE K30 | |
| Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | SILICON DIOXIDE | |
| Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | SODIUM LAURYL SULFATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing deferasirox
Detailed excipient profiles for deferasirox
Excipient focus: CASTOR OIL
deferasirox drug variants containing CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
| MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
| MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-200 |
| Novadoz Pharmaceuticals LLC | deferasirox | 72205-076 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing CASTOR OIL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
deferasirox drug variants containing CELLULOSE, MICROCRYSTALLINE
deferasirox drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
deferasirox drug variants containing CROSCARMELLOSE SODIUM
deferasirox drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
deferasirox drug variants containing CROSPOVIDONE
deferasirox drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 2
deferasirox drug variants containing FD&C BLUE NO. 2
deferasirox drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
deferasirox drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
| Xiromed LLC | deferasirox | 70700-269 |
| CELLTRION USA INC | deferasirox | 72606-013 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
deferasirox drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
deferasirox drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | deferasirox | 0591-3853 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
deferasirox drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | deferasirox | 69097-391 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
deferasirox drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
| MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROGENATED CASTOR OIL
deferasirox drug variants containing HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | deferasirox | 67877-549 |
| Ascend Laboratories LLC | deferasirox | 67877-552 |
| Ascend Laboratories LLC | deferasirox oral | 67877-675 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
deferasirox drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
| Bionpharma Inc | deferasirox | 69452-159 |
| MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
| MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-200 |
| Novadoz Pharmaceuticals LLC | deferasirox | 72205-076 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
deferasirox drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | deferasirox | 46708-410 |
| Alembic Pharmaceuticals Inc | deferasirox | 62332-410 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
deferasirox drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | deferasirox | 69238-1486 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
deferasirox drug variants containing HYPROMELLOSE 2910
deferasirox drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
deferasirox drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
| MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
deferasirox drug variants containing LACTOSE MONOHYDRATE
deferasirox drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
deferasirox drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | deferasirox | 67877-549 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
deferasirox drug variants containing MAGNESIUM STEARATE
deferasirox drug variants not containing MAGNESIUM STEARATE
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
deferasirox drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
| Actavis Pharma Inc | deferasirox | 0591-4730 |
| Camber Pharmaceuticals Inc | deferasirox | 31722-030 |
| Aurobindo Pharma Limited | deferasirox | 59651-410 |
| Cipla USA Inc | deferasirox | 69097-550 |
| NorthStar Rx LLC | deferasirox | 72603-231 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
deferasirox drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
| Aurobindo Pharma Limited | deferasirox | 59651-410 |
| Ascend Laboratories LLC | deferasirox | 67877-549 |
| NorthStar Rx LLC | deferasirox | 72603-231 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: MICROCRYSTALLINE CELLULOSE 200
deferasirox drug variants containing MICROCRYSTALLINE CELLULOSE 200
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | deferasirox | 31722-030 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing MICROCRYSTALLINE CELLULOSE 200
Excipient focus: POLOXAMER 188
deferasirox drug variants containing POLOXAMER 188
deferasirox drug variants not containing POLOXAMER 188
Excipient focus: POLOXAMER 407
deferasirox drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | deferasirox | 16714-993 |
| Zydus Pharmaceuticals USA Inc | deferasirox | 70710-1275 |
| Zydus Lifesciences Limited | deferasirox | 70771-1471 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing POLOXAMER 407
Excipient focus: POLYETHYLENE GLYCOL
deferasirox drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | deferasirox | 46708-410 |
| Alembic Pharmaceuticals Inc | deferasirox | 62332-410 |
| Ascend Laboratories LLC | deferasirox | 67877-552 |
| Amneal Pharmaceuticals NY LLC | deferasirox | 69238-1486 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
deferasirox drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | deferasirox | 0591-3853 |
| CELLTRION USA INC | deferasirox | 72606-013 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 4000
deferasirox drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | deferasirox | 57664-768 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
deferasirox drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
| Aurobindo Pharma Limited | deferasirox | 59651-410 |
| Xiromed LLC | deferasirox | 70700-269 |
| NorthStar Rx LLC | deferasirox | 72603-231 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
deferasirox drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | deferasirox | 16714-993 |
| Cipla USA Inc | deferasirox | 69097-391 |
| Zydus Pharmaceuticals USA Inc | deferasirox | 70710-1275 |
| Zydus Lifesciences Limited | deferasirox | 70771-1471 |
| CELLTRION USA INC | deferasirox | 72606-013 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
deferasirox drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| CELLTRION USA INC | deferasirox | 72606-013 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
deferasirox drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | deferasirox | 0591-3853 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
deferasirox drug variants containing POVIDONE
deferasirox drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
deferasirox drug variants containing POVIDONE K30
deferasirox drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
deferasirox drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
| MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
deferasirox drug variants containing SILICON DIOXIDE
deferasirox drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | deferasirox | 69097-391 |
| Cipla USA Inc | deferasirox | 69097-550 |
| Xiromed LLC | deferasirox | 70700-269 |
| CELLTRION USA INC | deferasirox | 72606-013 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
deferasirox drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | deferasirox | 67877-552 |
| Ascend Laboratories LLC | deferasirox oral | 67877-675 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
deferasirox drug variants containing SODIUM LAURYL SULFATE
deferasirox drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
deferasirox drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | deferasirox | 67877-549 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
deferasirox drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | deferasirox | 46708-324 |
| Alembic Pharmaceuticals Limited | deferasirox | 46708-410 |
| Alembic Pharmaceuticals Inc | deferasirox | 62332-324 |
| Alembic Pharmaceuticals Inc | deferasirox | 62332-410 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
deferasirox drug variants containing SODIUM STEARYL FUMARATE
deferasirox drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: TALC
deferasirox drug variants containing TALC
deferasirox drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
deferasirox drug variants containing TITANIUM DIOXIDE
deferasirox drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
deferasirox drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
| >Company | >Ingredient | >NDC |
deferasirox drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
